Institut fuer Diabetes forschung in Muenster (IDFM)

Münster 48145

0 studies enrolling now · 2 studies all time

What they study most

New-onset Type 1 Diabetes, Recent Onset type1 Diabetes

Studies at this site

• A Study of Oral Ladarixin in Recent Onset Type 1 Diabetes and a Low Residual β-cell Function — Stopped early
• A Study to Assess Efficacy/Safety of Ladarixin in Type 1 Diabetes Patients With Preserved ß-cell Function at Baseline. — Stopped early